pubmed-article:17452168 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17452168 | lifeskim:mentions | umls-concept:C0007226 | lld:lifeskim |
pubmed-article:17452168 | lifeskim:mentions | umls-concept:C2349001 | lld:lifeskim |
pubmed-article:17452168 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:17452168 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
pubmed-article:17452168 | lifeskim:mentions | umls-concept:C0008377 | lld:lifeskim |
pubmed-article:17452168 | lifeskim:mentions | umls-concept:C0681850 | lld:lifeskim |
pubmed-article:17452168 | lifeskim:mentions | umls-concept:C1706203 | lld:lifeskim |
pubmed-article:17452168 | lifeskim:mentions | umls-concept:C2697811 | lld:lifeskim |
pubmed-article:17452168 | lifeskim:mentions | umls-concept:C1705079 | lld:lifeskim |
pubmed-article:17452168 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
pubmed-article:17452168 | lifeskim:mentions | umls-concept:C0063695 | lld:lifeskim |
pubmed-article:17452168 | lifeskim:mentions | umls-concept:C0286651 | lld:lifeskim |
pubmed-article:17452168 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
pubmed-article:17452168 | lifeskim:mentions | umls-concept:C1337092 | lld:lifeskim |
pubmed-article:17452168 | lifeskim:mentions | umls-concept:C0333348 | lld:lifeskim |
pubmed-article:17452168 | lifeskim:mentions | umls-concept:C0205216 | lld:lifeskim |
pubmed-article:17452168 | lifeskim:mentions | umls-concept:C1522558 | lld:lifeskim |
pubmed-article:17452168 | lifeskim:mentions | umls-concept:C0162621 | lld:lifeskim |
pubmed-article:17452168 | lifeskim:mentions | umls-concept:C1550501 | lld:lifeskim |
pubmed-article:17452168 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:17452168 | lifeskim:mentions | umls-concept:C2745888 | lld:lifeskim |
pubmed-article:17452168 | lifeskim:mentions | umls-concept:C0205250 | lld:lifeskim |
pubmed-article:17452168 | lifeskim:mentions | umls-concept:C0456962 | lld:lifeskim |
pubmed-article:17452168 | lifeskim:mentions | umls-concept:C1521840 | lld:lifeskim |
pubmed-article:17452168 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:17452168 | pubmed:dateCreated | 2007-4-24 | lld:pubmed |
pubmed-article:17452168 | pubmed:abstractText | Plasma levels of soluble intercellular adhesion molecule 1 (sICAM-1) and monocyte chemoattractant protein 1 (sMCP-1) are associated with increased risk for future coronary events. However, the effect of statins on these inflammatory markers has hardly been studied. We analyzed whether treatment with the different doses of atorvastatin affects sICAM-1 and sMCP-1 plasma levels in subjects at high cardiovascular risk. | lld:pubmed |
pubmed-article:17452168 | pubmed:language | eng | lld:pubmed |
pubmed-article:17452168 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17452168 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:17452168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17452168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17452168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17452168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17452168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17452168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17452168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17452168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17452168 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17452168 | pubmed:month | May | lld:pubmed |
pubmed-article:17452168 | pubmed:issn | 1097-6744 | lld:pubmed |
pubmed-article:17452168 | pubmed:author | pubmed-author:Blanco-ColioL... | lld:pubmed |
pubmed-article:17452168 | pubmed:author | pubmed-author:FarsangCsabaC | lld:pubmed |
pubmed-article:17452168 | pubmed:author | pubmed-author:de... | lld:pubmed |
pubmed-article:17452168 | pubmed:author | pubmed-author:EgidoJesúsJ | lld:pubmed |
pubmed-article:17452168 | pubmed:author | pubmed-author:MartineauPier... | lld:pubmed |
pubmed-article:17452168 | pubmed:author | pubmed-author:GawAllanA | lld:pubmed |
pubmed-article:17452168 | pubmed:author | pubmed-author:LangerAnatoly... | lld:pubmed |
pubmed-article:17452168 | pubmed:author | pubmed-author:LeiterLawrenc... | lld:pubmed |
pubmed-article:17452168 | pubmed:author | pubmed-author:Martín-Ventur... | lld:pubmed |
pubmed-article:17452168 | pubmed:author | pubmed-author:GensiniGianFr... | lld:pubmed |
pubmed-article:17452168 | pubmed:author | pubmed-author:ACTFAST... | lld:pubmed |
pubmed-article:17452168 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:17452168 | pubmed:volume | 153 | lld:pubmed |
pubmed-article:17452168 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17452168 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17452168 | pubmed:pagination | 881-8 | lld:pubmed |
pubmed-article:17452168 | pubmed:meshHeading | pubmed-meshheading:17452168... | lld:pubmed |
pubmed-article:17452168 | pubmed:meshHeading | pubmed-meshheading:17452168... | lld:pubmed |
pubmed-article:17452168 | pubmed:meshHeading | pubmed-meshheading:17452168... | lld:pubmed |
pubmed-article:17452168 | pubmed:meshHeading | pubmed-meshheading:17452168... | lld:pubmed |
pubmed-article:17452168 | pubmed:meshHeading | pubmed-meshheading:17452168... | lld:pubmed |
pubmed-article:17452168 | pubmed:meshHeading | pubmed-meshheading:17452168... | lld:pubmed |
pubmed-article:17452168 | pubmed:meshHeading | pubmed-meshheading:17452168... | lld:pubmed |
pubmed-article:17452168 | pubmed:meshHeading | pubmed-meshheading:17452168... | lld:pubmed |
pubmed-article:17452168 | pubmed:meshHeading | pubmed-meshheading:17452168... | lld:pubmed |
pubmed-article:17452168 | pubmed:meshHeading | pubmed-meshheading:17452168... | lld:pubmed |
pubmed-article:17452168 | pubmed:meshHeading | pubmed-meshheading:17452168... | lld:pubmed |
pubmed-article:17452168 | pubmed:meshHeading | pubmed-meshheading:17452168... | lld:pubmed |
pubmed-article:17452168 | pubmed:meshHeading | pubmed-meshheading:17452168... | lld:pubmed |
pubmed-article:17452168 | pubmed:meshHeading | pubmed-meshheading:17452168... | lld:pubmed |
pubmed-article:17452168 | pubmed:meshHeading | pubmed-meshheading:17452168... | lld:pubmed |
pubmed-article:17452168 | pubmed:meshHeading | pubmed-meshheading:17452168... | lld:pubmed |
pubmed-article:17452168 | pubmed:meshHeading | pubmed-meshheading:17452168... | lld:pubmed |
pubmed-article:17452168 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17452168 | pubmed:articleTitle | Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration. | lld:pubmed |
pubmed-article:17452168 | pubmed:affiliation | Vascular Research Laboratory, Fundación Jimenéz Díaz, Autonoma University, Madrid, Spain. | lld:pubmed |
pubmed-article:17452168 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17452168 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:17452168 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:17452168 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17452168 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17452168 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17452168 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17452168 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17452168 | lld:pubmed |